¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"renal circulation"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • renal aminoaciduria
    ÄáÆÏ¾Æ¹Ì³ë»ê´¢, ½ÅÀ徯¹Ì³ë»ê´¢
  • renal anasarca
    ½ÅÀ强Àü½ÅºÎÁ¾
  • renal anuria
    ÄáÆÏ¹«´¢, ½ÅÀ强¹«´¢
  • renal aplasia
    ÄáÆÏ¹«Çü¼º, ½ÅÀ幫Çü¼º
  • renal apoplexy
    ÄáÆÏµÈÃâÇ÷, ½ÅÀåÁ¹Áß
  • renal arteriogram
    ÄáÆÏµ¿¸ÆÁ¶¿µ»ó, ½Å(Àå)µ¿¸ÆÁ¶¿µ»ó
  • renal arteriovenous fistula
    ÄáÆÏµ¿Á¤¸Æ»û±æ, ½ÅÀ嵿Á¤¸Æ·ç
  • renal artery
    ÄáÆÏµ¿¸Æ, ½ÅÀ嵿¸Æ
  • renal autotransplantation
    ÄáÆÏÀÚ°¡À̽Ä, ½ÅÀåÀÚ°¡À̽Ä
  • renal biopsy
    ÄáÆÏ»ý°Ë, ½ÅÀå»ý°Ë
  • renal calcinosis
    ÄáÆÏ¼®È¸Áõ, ½ÅÀ弮ȸÁõ
  • renal calculus
    ÄáÆÏµ¹, ½ÅÀå°á¼®
  • renal calyx
    ÄáÆÏÀÜ, ½Å¹è
  • renal cancer
    ÄáÆÏ¾Ï, ½ÅÀå¾Ï
  • renal cast
    ÄáÆÏ¿øÁÖ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • renal transplantation
    ÄáÆÏÀ̽Ä, ½ÅÀåÀ̽Ä
  • renal function test
    ÄáÆÏ±â´É°Ë»ç, ½ÅÀå±â´É°Ë»ç
  • renal vein thrombosis
    ÄáÆÏÁ¤¸ÆÇ÷ÀüÁõ, ½ÅÀåÁ¤¸ÆÇ÷ÀüÁõ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • renal calcinosis
    (¢¡nephrocalcinosis) ÄáÆÏ¼®È¸Áõ
  • renal calculus
    ÄáÆÏµ¹, ½ÅÀå¼®
  • renal calyx
    ÄáÆÏÀÜ, ½Å¹è
  • renal cast
    (¢¡urinary cast) ¿ä¿øÁÖ
  • renal column
    ÄáÆÏ±âµÕ, ½ÅÀå±âµÕ
  • renal crisis
    ÄáÆÏ±ÞÅëÁõ
  • renal vein catheterization
    ÄáÆÏÁ¤¸Æµµ°ü»ðÀÔ
  • renal disease
    ÄáÆÏº´, ½ÅÀ庴
  • renal disorder
    ÄáÆÏÀå¾Ö, ½ÅÀåÀå¾Ö
  • renal vascular disorder
    ÄáÆÏÇ÷°üÀå¾Ö, ½ÅÀåÇ÷°üÀå¾Ö
  • effective renal blood flow
    À¯È¿ÄáÆÏÇ÷·ù·®
  • effective renal plasma flow
    À¯È¿ÄáÆÏÇ÷Àå·ù·®
  • renal arteriovenous fistula
    ÄáÆÏµ¿Á¤¸Æ»û±æ, ½ÅÀ嵿Á¤¸Æ·ç
  • renal glycosuria
    ÄáÆÏ´ç´¢
  • renal ablation glomerulosclerosis
    ÄáÆÏÀýÁ¦Å丮±»À½Áõ, ½ÅÀýÁ¦»ç±¸Ã¼°æÈ­Áõ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • post-renal azotemia
    ½ÅÈļº(ãìý­àõ) Áú¼ÒÇ÷(Áõ)
  • radioisotope renal clearance method
    ¹æ»ç¼º µ¿À§¿ø¼Ò¼º ½ÅÁ¦°ÅÀ²ÃøÁ¤¹ý(¡­ê« áÈàõãìð¶ËÛëÒö´ïÒÛö).
  • radioisotope renal excretion test
    ¹æ»ç¼º µ¿À§¿ø¼Ò¼º ½Å¹è¼³½ÃÇè(¡­ãìÛÉàÜãË úÐ).
  • radionuclide renal scan
    ¹æ»ç¼ºÇÙÁ¾ ½ÅÁÖ»ç
  • renal
    ÄáÆÏÀÇ, ½ÅÀÇ, ½Å¼ºÀÇ.(ÇØºÎ)½ÅÀå(ãìíô)ÀÇ.
  • renal
    ½Å(ãì)ÀÇ,½ÅÀå(ãìíô)ÀÇ,½Å¼º(ãìàõ)ÀÇ, ÄáÆÏ(ÀÇ)
  • renal ablation glomerulosclerosis
    ½ÅÀýÁ¦»ç±¸Ã¼°æÈ­Áõ(ãìï·ð¶ÞêϹô÷Ìãûùñø)
  • renal abscess
    ½ÅÇÇÁú³ó¾ç
  • renal abscess
    ½Å³ó¾ç(ãìÒÛåË)
  • renal acidosis
    ½Å¼º»êÁõ.
  • renal acidosis
    ½Å¼º»êÁõ(ãìàõß«ñø)
  • renal adenocarcinoma
    ½Å ¼±¾Ï
  • renal adenoma
    ½Å¼±Á¾
  • renal agenesis
    ½Å¹«¹ßÀ°Áõ(ãìÙíÛ¡ëÀñø)
  • renal albuminuria
    ½Å¼º´Ü¹é´¢(ãìàõÓ±ÛÜèñ).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • juxtamedullary circulation
    ¹æ¼öÁú¼øÈ¯(Û¨âÐòõâàü»).
  • lung circulation
    Æó¼øÈ¯(øËâàü»).
  • muscle circulation
    ±Ù¼øÈ¯(ÐÉâàü»).
  • muscle circulation
    ±Ù ¼øÈ¯(ÐÉâàü»).
  • omphalomesenteric circulation
    Á¦Àå°£¸·¼øÈ¯(ð° ÊàØ¯âàü»).
  • parallel circulation
    ÆòÇà¼øÈ¯·Î.
  • peripheral circulation
    ¸»ÃʼøÈ¯(ØÇ âàü»).
  • persistent fetal circulation
  • placental circulation
    ŹݼøÈ¯(¡­âàü»).
  • portal circulation
    ¹®¸Æ¼øÈ¯(¡­âàü»).
  • pulmonary circulation time
    Æó¼øÈ¯½Ã°£(¡­ãÁÊà).
  • splanchnic circulation
    ³»Àå¼øÈ¯(Ò®íôâàü»).
  • splenic circulation
    ºñÀå¼øÈ¯(Þ¡íôâàü»).
  • systemic circulation
    ü¼øÈ¯(ô÷âàü»)
  • systemic circulation
    ü¼øÈ¯(ô÷âàü»).
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 14 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • Renal lobe
    ÄáÆÏ¿±
    [¿¾ ¿ë¾î] ½ÅÀå¼Ò¿±
  • Renal lobes
    ÄáÆÏ¿±
    [¿¾ ¿ë¾î] ½Å¿±
  • Renal papilla
    ÄáÆÏÀ¯µÎ
    [¿¾ ¿ë¾î] ½ÅÀ¯µÎ
  • Renal papillae
    ÄáÆÏÀ¯µÎ
    [¿¾ ¿ë¾î] ½ÅÀ¯µÎ
  • Renal impression
    ÄáÆÏÀÚ±¹
    [¿¾ ¿ë¾î] ½Å¾ÐÈç
  • Renal veins
    ÄáÆÏÁ¤¸Æ
    [¿¾ ¿ë¾î] ½ÅÁ¤¸Æ
  • Renal tissue (Nephroblastoma)
    ÄáÆÏÁ¶Á÷ (ÄáÆÏ¸ð¼¼Æ÷Á¾)
    [¿¾ ¿ë¾î] ½ÅÁ¶Á÷
  • Renal pyramid
    ÄáÆÏÇǶó¹Ô
    [¿¾ ¿ë¾î] ½ÅÃßü
  • Renal pyramids
    ÄáÆÏÇǶó¹Ô
    [¿¾ ¿ë¾î] ½ÅÃßü
  • Renal capsule
    ÄáÆÏÇǸ·
    [¿¾ ¿ë¾î] ½ÅÇǸ·
  • Renal blood vessel
    ÄáÆÏÇ÷°ü
    [¿¾ ¿ë¾î] ½ÅÀåÇ÷°ü
  • Major renal calices
    Å«(ÄáÆÏ)¼úÀÜ
    [¿¾ ¿ë¾î] ´ë½Å¹è
  • Base of renal pyramid
    ÇǶó¹Ô¹Ù´Ú
    [¿¾ ¿ë¾î] ÃßüÀú
  • Arcuate renal tubule
    Ȱ²Ã¼¼°ü
    [¿¾ ¿ë¾î] ±Ã»ó¿ä¼¼°ü
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • renal vein thrombosis
    ½ÅÁ¤¸ÆÇ÷ÀüÁõ
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
ADCC acute disorder of cerebral circulation; antibody-dependent cell-mediated cytotoxicity
circ & sens circulation and sensation
CMS children's medical services; Christian Medical Society; chronic myelodysplastic syndrome; chromosome...
CMSS circulation, motor ability, sensation, and swelling; Council of Medical Specialty Societies
CRAMS circulation, respiration, abdomen, motor, speech
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
ARN Afferent renal nerves
BMRTC Bone metastasising renal tumour of childhood
BOR Branchio-Oto-Renal
CRF CHRONIC RENAL FAILURE
CRD Chronic renal disease
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • renal angle
    ½Å°¢
  • renal aplasia
    ½Å¹«Çü¼º, ½Å ¹«Çü¼ºÁõ
  • renal arterial occlusion
    ½Åµ¿¸Æ Æó»ö
  • renal arteriography
    ½Åµ¿¸Æ Á¶¿µ¼ú
  • renal artery
    ½ÅÀå µ¿¸Æ, ½Åµ¿¸Æ, ÄáÆÏ µ¿¸Æ
    º¹µ¿¸ÆÀÇ ±½Àº °¡Áö¿¡¼­ Á¦ 2¿äÃß ³ôÀÌ¿¡¼­ Á¿ì 1´ë°¡ ºÐ±âÇϰí ÀÖ´Ù.
  • renal artery embolization
    ½Åµ¿¸Æ Æó¼â¼ú
  • renal artery stenosis
    ½Åµ¿¸Æ ÇùÂø
  • renal atheroembolic disease
    ½ÅÁ×»ó Àü»öº´, ½ÅÁ×Á¾ »öÀüº´
  • renal autonomic plexus
    ½Å ÀÚÀ² ½Å°æÃÑ
  • renal azotemia
    ½Å¼º °íÁú¼Ò Ç÷Áõ
  • renal bench surgery
    ü¿Ü ½Å¼ö¼ú
  • renal bleeding
    ½Å ÃâÇ÷
  • renal blood flow
    ½Å Ç÷·ù·®
  • renal calcinosis
    ½Å ¼®È¸È­Áõ
    µ¿ÀǾî=ne
  • renal calculi
    ½Å °á¼®
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
lesser circulation The circulation of blood through the lungs.
(12 Dec 1998)
liver circulation The circulation of blood through the vessels of the liver.
(12 Dec 1998)
lymph circulation The slow passage of lymph through the lymphatic vessels and glands.
(05 Mar 2000)
acute renal failure <nephrology> A sudden decline in renal function may be triggered by a number of acute disease processes.
Examples include sepsis (infection), shock, trauma, kidney stones, kidney infection, drug toxicity (aspirin or lithium), poisons or toxins (drug abuse) or after injection with an iodinated contrast dye (adverse effect).
Chronic renal failure represents a slow decline in kidney function over time. Chronic renal failure may be caused by a number of disorders which include long-standing hypertension, diabetes, congestive heart failure, lupus or sickle cell anaemia. Both forms of renal failure result in a life-threatening metabolic derangement.
(27 Sep 1997)
aminoaciduria, renal Impairment of renal tubular transport of amino acids.
(12 Dec 1998)
back-pressure renal atrophy <radiology> Caliectasis without obstruction, due to repeated episodes of obstruction, gradual loss of renal pyramids
(12 Dec 1998)
base of renal pyramid The outer broad part of a renal pyramid that lies next to the cortex.
Synonym: basis pyramidis renis.
(05 Mar 2000)
branchio-oto-renal syndrome <syndrome> An autosomal dominant disorder manifested by various combinations of preauricular pits, branchial fistulae or cysts, lacrimal duct stenosis, hearing loss, structural defects of the outer, middle, or inner ear, and renal dysplasia. Associated defects include asthenic habitus, long narrow facies, constricted palate, deep overbite, and myopia. Hearing loss may be due to mondini type cochlear defect and stapes fixation.
(12 Dec 1998)
capsular branches of renal artery <anatomy, artery> Branches arising from the renal artery outside of the kidney that are distributed to the renal capsule.
Synonym: rami capsulares arteriae renalis.
(05 Mar 2000)
captopril renal scan <radiology> In a kidney with a lesion in the afferent arteriole (e.g. Atherosclerotic plaque), reflex constriction of the efferent arteriole occurs through angiotensin system thus maintaining renal perfusion. ACE inhibition prevents constriction of efferent arteriole. Therefore, perfusion is decreased to a kidney with afferent lesions and the renal scan to looks WORSE. Bottom line: renal scans appear WORSE with captopril administration if there is a lesion in the afferent arteriole. See: renal artery stenosis
(12 Dec 1998)
carcinoma, renal cell Carcinoma of the renal parenchyma usually occurring in middle age or later and composed of tubular cells in varying arrangements. It was first described in 1826. Possible causal factors are environmental, hormonal, cellular, and genetic. Smoking is a definite risk factor and obesity is associated with increased risk. Renal cell carcinoma accounts for approximately 3% of adult cancer; the male-female ratio is 2:1. It is more common among urban residents than rural.
(12 Dec 1998)
renal <anatomy> Pertaining to the kidney, nephric.
(18 Nov 1997)
renal adenocarcinoma <radiology> Hypernephroma, renal cell carcinoma, arises from proximal collecting tubule, 10% bilateral adenocarcinoma types: papillary, alveolar, onchocytoma vascularity, 85% hypervascular (require pre-op embolization), 10% hypovascular (usually papillary type), 5% avascular associated with: tuberous sclerosis, von Hippel-Lindau syndrome see also: staging
(12 Dec 1998)
renal adenocarcinoma: staging <radiology> Typical presentation: Haematuria . . . . . 70% Fever . . . . . . . 16% Pain . . . . . . . . 50% Polycythemia . . . . 3% Palpable mass . . . 20% Anatomic staging (TNM): T1 Small tumour, kidney not enlarged T2 Large tumour, contained within renal capsule T3 Extension into perinephric fat or renal vein T4 Invasion of adjacent organs
(12 Dec 1998)
renal adenocarcinoma: vascularity <radiology> 85% hypervascular (require pre-op embolization), 10% hypovascular (usually the papillary type), 5% avascular also: 10% are bilateral
(12 Dec 1998)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
ÅëÇÕ°Ë»ö ¿Ï·á